| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
39,930,000 |
| Market
Cap: |
140.95(M) |
| Last
Volume: |
69,177 |
Avg
Vol: |
176,933 |
| 52
Week Range: |
$3.56 - $6.07 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Harvard Bioscience is a developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. Co.'s Cellular and Molecular Technologies (CMT) product family includes products designed primarily to support the discovery phase of new drug development. CMT products include syringe and peristaltic pump product lines, as well as a range of instruments and accessories for tissue, organ-based lab research. Co.'s Preclinical product family provides a platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
25,000 |
214,442 |
| Total Buy Value |
$0 |
$0 |
$109,500 |
$697,657 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
1 |
14 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Duchemin Jeffrey |
Chief Executive Officer |
• • – |
2018-03-09 |
4 |
S |
$4.60 |
$35,880 |
D/D |
(7,800) |
641,854 |
|
- |
|
| Sun Yong |
VP - Commercial Operations |
• – – |
2018-03-08 |
4 |
D |
$4.50 |
$11,426 |
D/D |
(2,539) |
204,858 |
|
- |
|
| Sun Yong |
VP - Commercial Operations |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,888 |
207,397 |
|
- |
|
| Duchemin Jeffrey |
Chief Executive Officer |
• • – |
2018-03-08 |
4 |
S |
$4.52 |
$358,083 |
D/D |
(79,222) |
649,654 |
|
- |
|
| Gagnon Robert E. |
Chief Financial Officer |
• – – |
2018-03-07 |
4 |
S |
$4.62 |
$448,542 |
D/D |
(97,087) |
357,938 |
|
- |
|
| Uveges George |
Director |
– • – |
2018-03-07 |
4 |
S |
$4.61 |
$161,599 |
D/D |
(35,054) |
163,028 |
|
- |
|
| Green James W |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
139,212 |
|
- |
|
| Kennedy John F |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,200 |
291,630 |
|
- |
|
| Loewald Thomas W |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
13,700 |
|
- |
|
| Loy Bertrand |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
117,750 |
|
- |
|
| Uveges George |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,200 |
198,082 |
|
- |
|
| Lewis Earl R |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,700 |
477,050 |
|
- |
|
| Eade Katherine A. |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,100 |
13,400 |
|
- |
|
| Duchemin Jeffrey |
Chief Executive Officer |
• • – |
2018-01-01 |
4 |
D |
$3.30 |
$198,356 |
D/D |
(60,108) |
728,876 |
|
- |
|
| Gagnon Robert E. |
Chief Financial Officer |
• – – |
2018-01-01 |
4 |
D |
$3.30 |
$66,158 |
D/D |
(20,048) |
455,025 |
|
- |
|
| Sun Yong |
VP - Commercial Operations |
• – – |
2018-01-01 |
4 |
D |
$3.30 |
$63,947 |
D/D |
(19,378) |
198,509 |
|
- |
|
| Loewald Thomas W |
Director |
– • – |
2017-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
2,300 |
|
- |
|
| Eade Katherine A. |
Director |
– • – |
2017-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
2,300 |
|
- |
|
| Uveges George |
Director |
– • – |
2017-09-07 |
4 |
D |
$3.25 |
$166,777 |
D/D |
(51,316) |
180,882 |
|
- |
|
| Uveges George |
Director |
– • – |
2017-09-07 |
4 |
OE |
$2.28 |
$166,778 |
D/D |
67,478 |
197,591 |
|
- |
|
| Duchemin Jeffrey |
Chief Executive Officer |
• • – |
2017-06-12 |
4 |
S |
$2.66 |
$58,520 |
D/D |
(22,000) |
788,984 |
|
- |
|
| Duchemin Jeffrey |
Chief Executive Officer |
• • – |
2017-06-12 |
4 |
B |
$2.76 |
$60,720 |
D/D |
22,000 |
810,984 |
2.81 |
- |
|
| Green James W |
Director |
– • – |
2017-06-08 |
4 |
B |
$2.55 |
$19,666 |
D/D |
7,712 |
110,212 |
2.39 |
- |
|
| Gagnon Robert E. |
Chief Financial Officer |
• – – |
2017-05-26 |
4 |
B |
$2.33 |
$2,330 |
D/D |
1,000 |
475,073 |
2.66 |
- |
|
| Lewis Earl R |
Director |
– • – |
2017-05-25 |
4 |
B |
$2.33 |
$28,765 |
D/D |
12,238 |
467,350 |
2.39 |
- |
|
650 Records found
|
|
Page 10 of 26 |
|
|
0.03 (0.84%) 
